Lozenge may be broken into smaller pieces if a lower dosage is desired
Los medicamentos agonistas del receptor GLP-1, como semaglutida y dulaglutida, se utilizan para tratar la diabetes tipo 2 y el manejo del peso corporal
doi: 10.1002/lim2.43
doi: 10.3389/fphar.2024.1457363 Received 30 June 2024 Accepted 22 August 2024 Published 04 September 2024 Volume 15 - 2024 Edited by Karuna Rasineni, University of Nebraska Medical Center, United States Reviewed by Luigi Losco, University of Salerno, Italy Sundararajan Mahalingam, University of Nebraska Omaha, United States Updates Copyright 2024 Brown, Tadros, Montagna, Bell, Crowley, Gallagher and Dayan
Disclosures The authors Saman Tauqir, Momina Israr, Bushra Rauf, Muhammad Omar Malik, Syed Hamid Habib, Fawad Ali Shah, Muhammad Usman, Muhammad Asif Raza, Inayat Shah, Haroon Badshah, Ehtesham Ehtesham, and Mohsin Shah have nothing to disclose